This was highlighted by Dr Sermed Mezher in a recent reel posted on Instagram, “People with KLS experience recurring episodes where they sleep excessively, sometimes up to 20 hours a day, for weeks at ...
Prenatal exposure to neuroinflammation (cytokines) may provide a biomarker for the risk of later development of Alzheimer's ...
Among 2024’s notable new drugs were three approvals for antibiotic therapies: Allecra Therapeutics’ Exblifep (cefepime and enmetazobactam), Basilea Pharmaceutica’s Zevtera (ceftobiprole ...
Alkermes wants to augment its pipeline with M&A or licensing deals in serious mental illnesses and substance abuse. “I think anyone who's developing a drug in these spaces, they are probably better ...
A large study of adults with ADHD found that 60% of these individuals reported some type of sleep disorder. Specifically, 36% reported having problems falling asleep (delayed sleep onset), 31% ...
The majority of individuals with idiopathic hypersomnia report that their disorder affects their social lives and romantic relationships.
Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...
ALKS-2680 is under clinical development by Synchronicity Pharma and currently in Phase I for Idiopathic Hypersomnia (IH). According to GlobalData, Phase I drugs for Idiopathic Hypersomnia (IH) have a ...
Space limited. Register now. Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental More than 90 percent of adults aged 65 and older take at least one prescription medication, ...
Drug coverage for four drugs used to treat some rare diseases was announced in Fredericton on Wednesday under a $32 million deal signed by the federal and provincial governments. Under the ...
The thyroid medication levothyroxine should be taken on an empty stomach at around the same time every day. You should avoid eating or drinking for 30 minutes to one hour after taking it. There are ...
First-in-class drugs are therapies that utilize novel mechanisms of action, offering new approaches to challenging diseases. In 2024, the U.S. Food and Drug Administration (FDA) approved 50 new ...